Phoenix Rising tells QMUL: release the PACE trial data
Mark Berry, Acting CEO of Phoenix Rising, presents the Board of Directors’ open letter to Queen Mary University of London (QMUL) urging them to release the PACE trial data, and hopes that other non-UK organisations will join British charities in the same request...
Discuss the article on the Forums.

Inhibiting CFH May Improve Responses to Rituximab

Discussion in 'Rituximab: News and Research' started by jaybee00, Jul 16, 2017.

  1. jaybee00

    jaybee00

    Messages:
    80
    Likes:
    94
  2. Gingergrrl

    Gingergrrl Senior Member

    Messages:
    9,920
    Likes:
    27,060
    USA
    I skimmed through the links and it appears to only be relevant for cancer (but hopefully someone more scientific than me can add to this).
     

See more popular forum discussions.

Share This Page